Skip to main content

AB 2442 — California

Peptides.

In committee 20252026 session Assembly

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Existing law establishes the State Department of Public Health, which, among other things, administers various programs that prevent disease and promote health.

This bill would create the California Investigational Peptide and Novel Compound Research and Therapeutic Access Program and would require the department to convene a working group with specified members to study and make recommendations regarding the creation of a state-authorized research and investigational therapeutic framework, as specified. The bill would require the working group to study potential uses of investigational therapeutic compounds and novel peptide compounds, among other things, and to submit a report to the Legislature detailing its findings and recommendations no later than January 1, 2029. The bill would repeal these provisions on January 1, 2030.

Official abstract, as published by the legislature.

  • AB 2442 is a bill in the California Assembly, 20252026 session, introduced February 20, 2026.
  • Current status: in committee.
  • Most recent action (May 14, 2026): In committee: Held under submission.
  • 2 recorded votes; the most recent, on April 21, 2026, passed 12-0.
  • Subjects: Peptides.

Contact your legislator about this bill

Bill text & documents

Sponsors

Cosponsors (1): Patterson

History

  1. Introduced, completed
  2. Passed Assembly, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Assembly Read first time. To print.
  2. Assembly From printer. May be heard in committee March 23.
  3. Assembly Referred to Coms. on HEALTH and JUD.
  4. Assembly From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
  5. Assembly Re-referred to Com. on HEALTH.
  6. Assembly Do pass and be re-referred to the Committee on [Judiciary] with recommendation: To Consent Calendar

    16 yes 0 no Passed, 100% yes

  7. Assembly From committee: Do pass and re-refer to Com. on JUD. with recommendation: To Consent Calendar. (Ayes 16. Noes 0.) (April 14). Re-referred to Com. on JUD.
  8. Assembly From committee chair, with author's amendments: Amend, and re-refer to Com. on JUD. Read second time and amended.
  9. Assembly Re-referred to Com. on JUD.
  10. Assembly Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar

    12 yes 0 no Passed, 100% yes

  11. Assembly From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 12. Noes 0.) (April 21). Re-referred to Com. on APPR.
  12. Assembly In committee: Set, first hearing. Referred to APPR. suspense file.
  13. Assembly In committee: Held under submission. Latest

Source: Open States. Last checked November 11, 2026. How we keep this accurate ›